Mrinalini Bilgi

Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes

Carlos A. Ramos, Brandon Ballard, Huimin Zhang et al. · Journal of Clinical Investigation · 2017 · 369 citations · Full text

Medicine, Immunology, Oncology +17

Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease

Stephen J. Simko, Huy D. Tran, Jeremy Jones et al. · Pediatric Blood & Cancer · 2013 · 136 citations

Medicine, Hematology, Oncology +16

Optimal Therapy for Adults with Langerhans Cell Histiocytosis Bone Lesions

M.A Quiroga Cantú, Philip J. Lupo, Mrinalini Bilgi et al. · PLoS ONE · 2012 · 128 citations · Full text

Medicine, Oncology, Pathology +11

Results from Lummicar-2: A Phase 1b/2 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Patients with Relapsed and/or Refractory Multiple Myeloma

Shaji Kumar, Rachid Baz, Robert Z. Orlowski et al. · Blood · 2020 · 57 citations

Medicine, Hematology, Immunology +13

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

Spyridoula Vasileiou, Premal Lulla, Ifigeneia Tzannou et al. · Journal of Clinical Oncology · 2021 · 48 citations · Full text

Life Sciences, Immunology, Oncology +17